title: Olanzapine-induced agranulocytosis: a case report and review of the literature.
abstract: The novel antipsychotic olanzapine has structural and pharmacological properties similar to clozapine. Until recently, no haematological toxicity has been reported with olanzapine use and it was expected to be a safer alternative. The authors report a case of agranulocytosis induced by olanzapine and reviewed the 11 cases reported in the literature.
authors.affiliation: Department of Internal Medicine, Consorci Sanitari Parc Taulí, Sabadell, Barcelona, Spain. ctolosa@cspt.es
authors.forename: Carles
authors.initials: C
authors.lastname: Tolosa-Vilella
authors.forename: Ada
authors.initials: A
authors.lastname: Ruiz-Ripoll
authors.forename: Begoña
authors.initials: B
authors.lastname: Mari-Alfonso
authors.forename: Elsa
authors.initials: E
authors.lastname: Naval-Sendra
mesh_terms: D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine